ISU Abxis Co., Ltd. (KOSDAQ:086890)
South Korea · Delayed Price · Currency is KRW 3,525.00
-5.00 (-0.14%)
At close: Sep 23, 2026
ISU Abxis Market Cap
ISU Abxis has a market cap or net worth of 143.73 billion as of September 25, 2026. Its market cap has decreased by -33.98% in one year.
Market Cap
143.73B
Enterprise Value
142.40B
Revenue
51.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,525.00
ChartMarket Cap Chart
Since February 3, 2009, ISU Abxis's market cap has increased from 55.97B to 143.73B, an increase of 156.82%. That is a compound annual growth rate of 5.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 143.73B | -30.13% |
| Dec 30, 2025 | 205.73B | 28.77% |
| Dec 30, 2024 | 159.77B | -23.70% |
| Dec 28, 2023 | 209.40B | 9.75% |
| Dec 29, 2022 | 190.80B | -34.58% |
| Dec 30, 2021 | 291.68B | 43.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| curacle co.,ltd. | 204.29B |
| Kangstem Biotech | 193.75B |
| NIBEC | 172.68B |
| Bio Solution | 166.44B |
| Kanaph Therapeutics | 158.54B |
| Ensol Biosciences | 146.64B |
| TiumBio | 134.42B |
| Y-Biologics | 122.93B |